
- BioPharm International's BP Elements, January 2023
- Volume 2
- Issue 1
Getinge Announces New BioProcess Control System
Getinge is launching Livit Flex, a bioprocess control system designed to help pharmaceutical and biotech products get to market faster.
Getinge, a Swedish medical technology company, announced the launch of the LivitFlex bioprocess control system. The system is designed to help pharmaceuticals and biotechnology products reach market faster.
According to a Dec. 15, 2022 press release, the LivitFlex speeds up development through system flexibility, smart sensor technology, and easy-to-use software functionalities. Additionally, by accessing and controlling multiple controllers from a PC or tablet in a laboratory, users can set up parallel experiments and monitor all data from one central location.
“Combining the flexibility of the Livit Flex controller, the intuitive Livit software, and Getinge bioreactors enables acceleration of R&D processes to make sure that pharmaceuticals and biotech products will ultimately end up faster where they are most needed – with the patients,” said Matthijs Niemeijer, head, Product Management Bioreactor Systems, Getinge, in the release.
Source:
Articles in this issue
over 2 years ago
Finding Solutions to Manage mRNA Instabilityalmost 3 years ago
Merck Licenses Kelun-Biotech ADC’s in Deal Worth $9.3 Billionalmost 3 years ago
Massive Government Spending Bill Tackles Key FDA and Research Issuesalmost 3 years ago
Discovery Life Sciences Now Offers Large-Scale Proteomic Servicesalmost 3 years ago
AbCellera and Rallybio Partner on Novel Antibody-Based Therapeuticsalmost 3 years ago
Catalent to Expand its Biologics Analytical Services with New FacilityNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.